United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study

NAUnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

December 31, 2012

Conditions
DiabetesCoronary Artery Disease
Interventions
DRUG

Strict Glycemic Control for one year post-op CABG

"The CDE and Study Coordinator will also meet with the patient in the hospital to show how the Lifescan One-Touch Ultra II glucometer works and review the study follow-up schedule. Patients will be sent home with the Lifescan One-Touch Ultra II glucometer and a supply of strips.~Post-Discharge Period Patients will meet alternatively with the CDE and study doctor on a specific schedule including every week for the first month, every 2 weeks in the second month, and every month thereafter till the 12th month. During these sessions the BG records will be downloaded from the Lifescan One-Touch Ultra II glucometer and reviewed to see patterns and any areas that could be improved or changed.~For all patients in the study arm, the medications that are being taken and the results of glucose monitoring charts will be reviewed weekly with endocrinologists so that any additional recommendations may be made to improve glucose control."

Trial Locations (1)

97225

Providence St. Vincent Medical Center, Portland

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

LifeScan

INDUSTRY

lead

Providence Heart & Vascular Institute

OTHER

NCT00646438 - United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study | Biotech Hunter | Biotech Hunter